133 related articles for article (PubMed ID: 1157009)
1. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
[TBL] [Abstract][Full Text] [Related]
2. The urinary excretion of the nucleosides pseudouridine and 1-methylinosine during normal menstrual cycle.
Lehtiö H; Mäenpää PH
Clin Chim Acta; 1977 Oct; 80(1):181-5. PubMed ID: 908140
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine.
Waalkes TP; Dinsmore SR; Mrochek JE
J Natl Cancer Inst; 1973 Jul; 51(1):271-4. PubMed ID: 4720877
[No Abstract] [Full Text] [Related]
4. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
[TBL] [Abstract][Full Text] [Related]
5. Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatography.
Chang SY; Lakings DB; Zumwalt RW; Gehrke CW; Waalkes TP
J Lab Clin Med; 1974 May; 83(5):816-30. PubMed ID: 4821860
[No Abstract] [Full Text] [Related]
6. Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patients.
Mrochek JE; Dinsmore SR; Waalkes TP
J Natl Cancer Inst; 1974 Dec; 53(6):1553-63. PubMed ID: 4474409
[No Abstract] [Full Text] [Related]
7. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
Coombes RC; Powles TJ; Gehrke CW; Waalkes TP; Neville AM
Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
[TBL] [Abstract][Full Text] [Related]
8. Composition, associated tissue methyltransferase activity, and catabolic end products of transfer RNA from carcinogen-induced hepatoma and normal monkey livers.
Lakings DB; Waalkes TP; Borek E; Gehrke CW; Mrochek JE; Longmore J; Adamson RH
Cancer Res; 1977 Jan; 37(1):285-92. PubMed ID: 187335
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
Heldman DA; Grever MR; Speicher CE; Trewyn RW
J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
[TBL] [Abstract][Full Text] [Related]
10. Possible use of urinary modified RNA metabolites in the measurement of RNA turnover in the human body.
Sander G; Topp H; Wieland J; Heller-Schöch G; Schöch G
Hum Nutr Clin Nutr; 1986 Mar; 40(2):103-18. PubMed ID: 2420752
[TBL] [Abstract][Full Text] [Related]
11. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
Heldman DA; Grever MR; Miser JS; Trewyn RW
J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleic acid turnover in man:RNA catabolites in urine as measure for the metabolism of each of the three major species of RNA.
Sander G; Topp H; Heller-Schöch G; Wieland J; Schöch G
Clin Sci (Lond); 1986 Oct; 71(4):367-74. PubMed ID: 2428556
[TBL] [Abstract][Full Text] [Related]
13. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L
Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364
[TBL] [Abstract][Full Text] [Related]
14. Determination of 7-methylguanine, N2,N2-dimethylguanosine, and pseudouridine in ultrafiltrated serum of healthy adults by high-performance liquid chromatography.
Topp H; Sander G; Heller-Schöch G; Schöch G
Anal Biochem; 1987 Feb; 161(1):49-56. PubMed ID: 2437827
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids.
Davis GE; Suits RD; Kuo KC; Gehrke CW; Waalkes TP; Borek E
Clin Chem; 1977 Aug; 23(8):1427-35. PubMed ID: 872405
[No Abstract] [Full Text] [Related]
16. Differential excretion of modified nucleosides in adult acute leukemia.
Heldman DA; Grever MR; Trewyn RW
Blood; 1983 Feb; 61(2):291-6. PubMed ID: 6571786
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of N2, N2-dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy.
Levine L; Waalkes TP; Stolbach L
J Natl Cancer Inst; 1975 Feb; 54(2):341-3. PubMed ID: 1117461
[TBL] [Abstract][Full Text] [Related]
18. Undermethylated transfer ribonucleic acid from a relaxed strain of Bacillus subtilis: construction of the strain and analysis of the transfer ribonucleic acid.
Keisel N; Vold B
J Bacteriol; 1976 Apr; 126(1):294-9. PubMed ID: 816774
[TBL] [Abstract][Full Text] [Related]
19. Pyrimidine nucleoside, pseudouridine, and modified nucleoside excretion by growing and resting fibroblasts.
Uziel M; Selkirk JK
J Cell Physiol; 1979 May; 99(2):217-22. PubMed ID: 457787
[TBL] [Abstract][Full Text] [Related]
20. [Interrelationship of pseudouridine and transfer RNA metabolic disorders in thermal injury].
Salomatin VV; Efimenko GP; Kamilov FKh; Lifshits RI
Vopr Med Khim; 1977; 23(5):642-6. PubMed ID: 595499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
